Brachytherapy Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Brachytherapy Devices Market: By Type (High Dose Rate Brachytherapy and Low Dose Rate Brachytherapy), By Application (Gynaecological Cancer, Prostate Cancer, Skin Cancer, Breast Cancer, Cervical Cancer, and Others), By End User (Hospitals, Diagnostic Centres, Ambulatory Surgical Centres, and Radiotherapy Centres), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Brachytherapy Devices Market size is valued at USD 792.2 million in 2021 and is expected to grow at a CAGR of 7.4% during the forecast period 2022 to 2028. The global market provides a detailed overview of the Brachytherapy Devices market and which can be segmented by type, application, end-user, and region. By type, the Brachytherapy Devices market has been segmented into high dose rate brachytherapy and low dose rate brachytherapy. By type, the high dose rate brachytherapy segment dominated the market and accounted for the largest revenue share in past years. The high dose rate therapy is generally done as an outpatient procedure for the treatment of various types of cancers such as skin, cervical, prostate, head, neck, and breast cancer within a short procedure time, higher efficacy, and protection from radiation exposure. By application, the Brachytherapy Devices market has been segmented into gynecological cancer, prostate cancer, skin cancer, breast cancer, cervical cancer, and others. By application, the breast cancer segment is expected to witness the highest CAGR during the forecast period owing to the increasing usage of brachytherapy in accelerated partial breast irradiation (APBI). Furthermore, the rising incidence of breast cancer is also expected to propel the growth of this segment. Based on the end user, the segment has been segregated into hospitals, diagnostic centers, ambulatory surgical centers, and radiotherapy centers. The radiotherapy centers segment is expected to lead the end-user segments owing to continuous development in cancer treatment devices by numerous radiotherapy centers across developed countries.

 

Key Development:

In July 2021, Genesis Care extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices.

Brachytherapy Devices Market

MARKET SUMMARY
-
7.4% CAGR
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 7.4%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Brachytherapy Devices Market

  • The report on global brachytherapy devices market gives historical, current, and future market sizes (US$ Mn) on the basis of type, application, end user and geography.
  • The brachytherapy devices market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Varian Medical Systems, Inc. (U.S.)
  • Ion Beam Applications (IBA) (Belgium)
  • Accuray Incorporated (U.S.)
  • Nordion, Inc. (Canada)
  • Elekta AB (Sweden)
Brachytherapy Devices Market Dynamics

The rising prevalence of cancer, technological advancements, and a substantial rise in the adoption of brachytherapy are expected to drive the growth of the market during the forecast period.


North-America Got Significant Share

Brachytherapy Devices Market

North America market is expected to witness a significant market share during the forecast period owing to the well-developed healthcare facilities and rising cancer patient population across the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, country market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Brachytherapy Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

Based on dosage type, High-Dose Rate (HDR) brachytherapy segment held the largest share in 2020, due to various advantages such as short procedure time, higher efficacy, and protection from radiation exposure.

The increasing prevalence of cancer, technological advancements, and the rise in the adoption of brachytherapy is expected to drive the growth of the market during the forecast period.

The prostate cancer segment dominated the global brachytherapy market and accounted for the largest revenue share in the historic period due to the rising prevalence of prostate cancer across the globe.

North America dominated the global brachytherapy market and held a significant market share, and would expect to expand the global market by making huge investments in healthcare sectors.


Report

Table Of Content


Report

Company Profile

  • Varian Medical Systems, Inc. (U.S.)
  • Ion Beam Applications (IBA) (Belgium)
  • Accuray Incorporated (U.S.)
  • Nordion, Inc. (Canada)
  • Elekta AB (Sweden)
  • Isoray Medical, Inc. (U.S.)
  • R. Bard, Inc. (U.S.)
  • ViewRay, Inc. (U.S.)
  • RaySearch Laboratories (Sweden)
  • Mitsubishi Electric Corporation (Japan)
  • Mevion Medical Systems, Inc. (U.S.)

Description

Brachytherapy Devices Market size is valued at USD 792.2 million in 2021 and is expected to grow at a CAGR of 7.4% during the forecast period 2022 to 2028. The global market provides a detailed overview of the Brachytherapy Devices market and which can be segmented by type, application, end-user, and region. By type, the Brachytherapy Devices market has been segmented into high dose rate brachytherapy and low dose rate brachytherapy. By type, the high dose rate brachytherapy segment dominated the market and accounted for the largest revenue share in past years. The high dose rate therapy is generally done as an outpatient procedure for the treatment of various types of cancers such as skin, cervical, prostate, head, neck, and breast cancer within a short procedure time, higher efficacy, and protection from radiation exposure. By application, the Brachytherapy Devices market has been segmented into gynecological cancer, prostate cancer, skin cancer, breast cancer, cervical cancer, and others. By application, the breast cancer segment is expected to witness the highest CAGR during the forecast period owing to the increasing usage of brachytherapy in accelerated partial breast irradiation (APBI). Furthermore, the rising incidence of breast cancer is also expected to propel the growth of this segment. Based on the end user, the segment has been segregated into hospitals, diagnostic centers, ambulatory surgical centers, and radiotherapy centers. The radiotherapy centers segment is expected to lead the end-user segments owing to continuous development in cancer treatment devices by numerous radiotherapy centers across developed countries.

 

Key Development:

In July 2021, Genesis Care extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX